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Abstract: 
The ability of stressful life events to trigger drug use is particularly 
problematic for the management of cocaine addiction due to the 
unpredictable and often uncontrollable nature of stress. For this reason, 
understanding the neurobiological processes that contribute to stress-related 
drug use is important for the development of new and more effective 
treatment strategies aimed at minimizing the role of stress in the addiction 
cycle. In this review we discuss the neurocircuitry that has been implicated in 
stress-induced drug use with an emphasis on corticotropin releasing factor 
actions in the ventral tegmental area (VTA) and an important pathway from 
the bed nucleus of the stria terminalis to the VTA that is regulated by 
norepinephrine via actions at beta adrenergic receptors. In addition to the 
neurobiological mechanisms that underlie stress-induced cocaine seeking, we 
review findings suggesting that the ability of stressful stimuli to trigger 
cocaine use emerges and intensifies in an intake-dependent manner with 
repeated cocaine self-administration. Further, we discuss evidence that the 
drug-induced neuroadaptations that are necessary for heightened 
susceptibility to stress-induced drug use are reliant on elevated levels of 
glucocorticoid hormones at the time of cocaine use. Finally, the potential 
ability of stress to function as a “stage setter” for drug use – increasing 
sensitivity to cocaine and drug-associated cues – under conditions where it 
does not directly trigger cocaine seeking is discussed. As our understanding of 
the mechanisms through which stress promotes drug use advances, the hope 
is that so too will the available tools for effectively managing addiction, 
particularly in cocaine addicts whose drug use is stress-driven. 
Keywords: Cocaine, Stress, Relapse, Norepinephrine, CRF, Glucocorticoid, 
Review. 
 
1. Stress-related cocaine use: evidence from 
human addicts 
An accumulating body of evidence suggests that there is a 
strong relationship between stress and drug use by cocaine addicts. 
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Anecdotal reports suggesting that stressful life events can precipitate 
relapse are paralleled by laboratory findings that the presentation of 
pre-recorded individualized stress-related scripts can induce craving in 
cocaine-dependent individuals (Sinha et al., 1999, 2000) and by 
epidemiological studies demonstrating high rates of co-morbidity 
between cocaine dependence and a number of stress-related 
disorders, including depression, anxiety, and post-traumatic stress 
disorder (PTSD; Rounsaville et al., 1991; Chen et al., 2011). In fact, it 
is likely that most incidents of relapse in cocaine addicts are in some 
way stress-related. In the case of PTSD, morbidity is not only higher in 
cocaine-dependent individuals (Cottler et al., 1992), but in many cases 
traumatic events predate cocaine use (Brady et al., 1998) and imagery 
based on the traumatic episode can elicit drug craving (Coffey et al., 
2002). Indeed, one study noted that 95% of individuals with co-
morbid PTSD and cocaine dependence reported a functional 
relationship between PTSD-related symptoms and drug use, with 86% 
reporting that a worsening of symptoms resulted in increased cocaine 
use (Back et al., 2006). While it is clear that a relationship exists 
between stress and cocaine use, the precise contribution of stress to 
the addiction process remains unclear and in many cases likely 
involves a complex interaction between stressful stimuli, cocaine-
related cues, and the effects of the drug itself and may vary across 
different subpopulations of addicts (Preston and Epstein, 2011). These 
effects of stress on cocaine use are particularly problematic due to 
their unavoidable nature, making stress a key target for interventions 
aimed at relapse prevention. Thus, understanding the neurobiological 
processes that mediate the influence of stress on cocaine use is 
important for devising new and more effective therapeutic approaches 
for the management of addiction. 
2. Rodent models for studying stress-induced 
relapse 
The contribution of stress to drug relapse can be studied pre-
clinically using reinstatement-based designs in which the ability of 
various stressful stimuli to re-establish extinguished cocaine seeking is 
assessed in rats or mice. Despite some concerns about their construct 
validity (e.g., extinction of behavior in rodents is not the same as 
abstinence in human addicts) and their predictive validity (it is not 
clear that these approaches can be used to reliably identify effective 
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relapse interventions), these approaches have been critical in shaping 
our understanding of the neurobiological pathways that contribute to 
stress-related drug use. Brief over-views of the two primary variations 
of these approaches, as applied in our laboratory, are provided below. 
Representative graphs depicting stress-induced cocaine seeking as 
measures using these approaches are shown in Fig. 1. 
 
Fig. 1 Stress-induced cocaine seeking in mouse (A–C) and rat (D–F) models. 
Stress-induced reinstatement of extinguished cocaine-induced CPP is shown in Figs. A-
C. Preference for a cocaine-paired compartment (4 × 15 mg/kg, ip) was established 
(A; increase in time spent post-conditioning vs. pre-conditioning) and extinguished (B) 
in C57BL/6 mice (n = 4) prior to reinstatement of preference by pre-exposure to a 
forced swim session (C; 6-min swim in 22 °C water; *P < 0.05 vs. Bas). Stress-
induced reinstatement in rats following cocaine self-administration and extinction is 
shown in Figs. D–F. Following training, rats (n = 5) self-administered cocaine (1.0 
mg/kg/inf) by pressing a lever during daily 6-h sessions for 14 days (D) prior to 
undergoing extinction over a 10-day period during daily 2-h sessions (E) and 
reinstatement testing (F). Stress-induced reinstatement was observed as the ability of 
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footshock stress (0.5 mA; 0.5” duration delivered an ave. of 40-s apart over a 15-min 
session) to increase responding on the cocaine lever (*P < 0.05 vs. Bas). 
2.1. Self-administration/reinstatement approaches in 
rats 
In rats, the study of relapse typically involves testing for the 
reinstatement of extinguished responding following intravenous 
cocaine self-administration (SA). Although a variety of stressors have 
been demonstrated to reinstate cocaine seeking following SA in rats, 
including food restriction (Shalev et al., 2003) and forced swim 
(Conrad et al., 2010), the most common method involves the use of 
uncontrollable intermittent electric footshock delivered through the 
grid floors of the SA chambers (Ahmed and Koob, 1997; Erb et al., 
1996). Notably, while a number of laboratories have demonstrated 
footshock-induced reinstatement of cocaine seeking following SA in 
rats, the conditions under which reliable rein-statement has been 
observed are very specific (see e.g., Shelton and Beardsley, 2005) 
and, in our hands, depend on a history of SA under conditions of 
prolonged daily access (Mantsch et al., 2008a,b). 
2.2. Conditioned place preference/reinstatement 
approaches in mice 
Methodological considerations limit the utility of SA-based 
approaches in mice. Instead, relapse is commonly studied in mice by 
examining the ability of stressors to re-establish preference for a 
cocaine-paired environment following the extinction of cocaine-induced 
conditioned place preference (CPP). As is the case with the SA 
approach in rats, a number of stressors, including social stress (Ribeiro 
Do Couto et al., 2006) and uncontrollable electric footshock (Redila 
and Chavkin, 2008), have been demonstrated to reinstate 
extinguished drug-induced CPP in mice. However, the most frequently 
applied approach, and the one used in our laboratory, involves a brief 
(6-min) forced swim at 22 °C prior to transfer to the conditioning 
apparatus (Kreibich and Blendy, 2004; Mantsch et al., 2008a,b). 
Go to: 
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3. Anatomy of stress-induced relapse 
3.1. Overview of the neurocircuitry implicated in stress-
induced reinstatement 
Using the reinstatement approach in rodents, we and others 
have begun to define the neurocircuitry involved in stress-induced 
cocaine seeking. A putative circuit for stress-induced cocaine use is 
included in Fig. 2. Like other reinstating stimuli (e.g., priming 
injections of cocaine and cocaine-associated cues; see Kalivas and 
McFarland, 2003 for review) stress-induced reinstatement appears to 
involve a corticostriatal glutamatergic projection from the prelimbic 
cortex to the nucleus accumbens (NAc) core which likely regulates 
striato-pallidal outputs to produce drug seeking. Accordingly, 
McFarland et al. (2004) demonstrated that inhibition of the NAc core 
using a GABA receptor agonist cocktail blocks footshock-induced 
reinstatement in rats while several groups have found that dopamine 
(DA) D1 receptor antagonism in the medial prefrontal cortex (mPFC) 
prevents stress-induced cocaine seeking (Capriles et al., 2003; 
Sanchez et al., 2003; McFarland et al., 2004). In the PFC, D1 DA 
receptors are expressed on pyramidal cells, including those that 
project to the NAc core, where they promote excitability primarily by 
increasing NMDA receptor-mediated excitability (Lewis and O’Donnell, 
2000; Seamans et al., 2001). However, D1 receptors are also found 
on fast-spiking GABAergic interneurons which they inhibit to further 
increase pyramidal cell excitability (Gonzalez-Islas and Hablitz, 2001). 
The latter mechanism could account for fMRI studies in human addicts 
showing that BOLD signal is reduced during stress-induced craving 
(Sinha et al., 2005). Dopaminergic projections to the mPFC arise from 
the ventral tegmental area (VTA), which appears to be a key 
integration site at which inputs that relay stress- and drug 
context/cue-related information converge. Brain structures upstream 
from this mesocortical pathway that are necessary for stress-induced 
relapse appear to include the bed nucleus of the stria terminalis 
(BNST), the central nucleus of the amygdala (CeA), and the NAc shell 
(McFarland et al., 2004; Briand et al., 2010). Collectively, these 
regions are often considered to comprise a larger complex, termed the 
extended amygdala, based on their anatomical similarities. Recently, a 
number of laboratories, including ours, have begun to explore the 
mechanisms within the VTA through which stressors regulate cocaine-
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seeking behavior as well as the potential role of inputs from 
components of the extended amygdala – particularly the BNST (Geisler 
and Zahm, 2005; Dong and Swanson, 2006) – in promoting drug use 
during periods of stress. 
 
Fig. 2 Ongoing areas of research on the mechanisms through which stress promotes 
cocaine use. One putative pathway that underlies stress-induced reinstatement is a 
key corticotropin releasing factor- (CRF-) releasing pathway from the bed nucleus of 
the stria terminalis (BNST) to the ventral tegmental area (VTA) that is regulated by 
norepinephrine released from noradrenergic projections primarily from medullary 
noradrenergic cells groups and appears to be partly under the control of an input from 
the central nucleus of the amygdala (CeA). In the BNST, beta adrenergic receptors 
and CeA projections appear to induce cocaine seeking via local release of CRF and 
BNST CRF-R1 receptor activation. In the VTA, BNST inputs converge with afferents 
from other regions, including the nucleus accumbens (NA) shell and the CeA to 
regulate dopamine (DA) release in the prelimbic cortex (PLC). DA in the PLC cortex 
promotes excitation of a glutamatergic pathway to the NA core that has been 
proposed to function as a common final pathway through which a range of stimuli 
induces cocaine seeking. Current areas of research focus in our lab include 
investigation of: 1) the CRF-releasing pathway from the BNST to the VTA and its 
regulation by beta-2 adrenergic receptors; 2) the mechanisms through which CRF-R1 
receptor activation in the VTA regulate DA projections; 3) glucocorticoid-dependent 
processes in these regions through which stress can “set the stage” for cocaine use, 
including glucocorticoid inhibition of the monoamine transporter, organic cation 
transporter 3 (OCT3) and glucocorticoid regulation of endocannabinoid (eCB) 
production; and 4) glucocorticoid-dependent neuroplasticity in these pathways that 
increases susceptibility to cocaine seeking and contributes to the onset of addiction. 
Other abbreviations: glutamate (GLU). 
 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol. 76, No. Part B (January 2014): pg. 383-394. DOI. This article is © Elsevier and permission has 
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article 
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
8 
 
3.2. A BNST to VTA projection 
Although the neuroanatomy of stress-induced cocaine use is 
complex and almost certainly involves the coordinated activity of 
numerous inputs that converge upon the VTA to integrate emotion-, 
context-, and memory-related signals, one pathway that stands out as 
a key regulator of drug use is a projection from the BNST to the VTA. 
The BNST has long been known to serve as an important site at which 
stress-related responses are integrated. Towards this end, the BNST 
receives dense innervation from a number of structures involved in 
stressor-responsiveness, most notably heavy brainstem noradrenergic 
inputs from the locus coeruleus and medullary cell groups (see Smith 
and Aston-Jones, 2008 for review) and a prominent projection from 
the CeA (Zahm et al., 1999). Indeed, the BNST, through its 
projections to the hypothalamus, is a key regulator of the hormonal 
stress response (Forray and Gysling, 2004). Additionally, the BNST has 
reciprocating connectivity with the VTA from which it receives DA 
inputs, thus positioning it as a potential interface between stress and 
motivated behavior and therefore as a site at which stressors could 
promote drug use. Accordingly, inhibition of the BNST attenuates 
stress-induced reinstatement in both rat (McFarland et al., 2004) and 
mouse (Briand et al., 2010) models. Recent work from our lab and 
others suggests that brainstem adrenergic inputs into the BNST, likely 
in coordination with projections from the CeA, regulate a pathway that 
ultimately releases the neuropeptide corticotropin-releasing factor 
(CRF) into the VTA. A major focus of the current research in our lab 
involves understanding the mechanisms through which CRF in the VTA 
and norepinephrine (NE) in the BNST promote cocaine seeking. 
4. A role for CRF in stress-induced relapse 
CRF is a 41 amino acid neuropeptide that plays a key role in 
regulating both the hormonal and behavioral responses to stressors. 
CRF produces it effects via two receptors, both of which are Gs G-
protein coupled but may also activate other signaling pathways cite 
(see Behan et al., 1996 for review): 1) the CRF-R1 receptor, which has 
a higher affinity for CRF and has a relatively widespread expression 
pattern in the brain and 2) the CRF-R2 receptor, which has a lower 
affinity for CRF and a more restricted pattern of expression. Notably, 
the CRF-R2 receptor preferentially binds to a family of CRF-related 
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peptides, the urocortins, and may interact with CRF more effectively 
via a mechanism that also involves the CRF binding protein. 
4.1. CRF and stress-induced reinstatement 
CRF is a key regulator of stress-induced reinstatement. We and 
others have shown that systemic or intra-cerebroventricular (icv) 
administration of CRF receptor antagonists prevents footshock-induced 
reinstatement in rats (Erb et al., 1998; Shaham et al., 1997; Graf et 
al., 2011) while central administration of CRF alone can induce cocaine 
seeking (Erb et al., 2006; Mantsch et al., 2008a,b). The role of CRF in 
stress-induced reinstatement is independent of its regulation of the 
hypothalamice–pituitary–adrenal (HPA) axis. Eliminating the plasma 
corticosterone response via surgical adrenalectomy and basal 
corticosterone replacement does not attenuate reinstatement by either 
footshock (Erb et al., 1998; Graf et al., 2011) or icv CRF 
administration (Graf et al., 2011). Although blocking CRF receptors 
prevents stressor-induced rein-statement, it has no effect on 
reinstatement by a priming injection of cocaine (Erb et al., 1998; Graf 
et al., 2011), suggesting that the pathways underlying stress-induced 
relapse may be distinct from those that mediate drug use in response 
to other triggers. 
4.2. Role of CRF in the VTA in stressor-induced 
reinstatement 
The VTA is a key site for CRF regulation of cocaine seeking. Both 
CRF-R1 and CRF-R2 receptors (Goeders et al., 1990; Van Pett et al., 
2000; Korotkova et al., 2006) as well as the CRF binding protein 
(Wang and Morales, 2008) are expressed in the VTA which receives 
CRF positive projections from several brain regions, including the BNST 
(Rodaros et al., 2007). Correspondingly, extracellular CRF levels in the 
VTA, as measured using in vivo microdialysis and radioimmunoassay, 
are increased during footshock-induced rein-statement in rats (Wang 
et al., 2005). We and others have found that delivery of CRF directly 
into the VTA is sufficient to reinstate cocaine seeking following SA in 
rats, while intra-VTA CRF receptor antagonist administration prevents 
footshock-induced reinstatement (Wang et al., 2005, 2007; Blacktop 
et al., 2011). 
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4.2.1. Role for CRF-R1 receptors  
While it is generally agreed that CRF release in the VTA is 
required for stress-induced reinstatement, the receptor subtype that 
mediates the effects of CRF on cocaine seeking is controversial. Using 
the SA/reinstatement approach in rats, we have found that the CRF-R1 
but not the CRF-R2 receptor in the VTA is necessary for CRF- and 
stress-induced reinstatement, and that activation of the CRF-R1 
receptor in the VTA alone is sufficient to reinstate cocaine seeking 
(Blacktop et al., 2011). Intra-VTA pretreatment with the CRF-R1 
receptor-selective antagonists antalarmin or CP-376395 blocks 
reinstatement in response to delivery of CRF into the VTA or footshock 
without producing response-limiting sedative effects, while intra-VTA 
pretreatment with the CRF-R2 receptor-selective antagonist 
astressin2B has no effect. Similarly the reinstating effects of footshock 
and intra-VTA CRF are reproduced by administration of the CRF-R1 
receptor-selective agonist, cortagine, into the VTA but not the CRF-R2 
receptor-selective agonist, rat urocortin 2. These findings are 
consistent with reports that systemic administration of antalarmin also 
blocks stress-induced reinstatement of cocaine seeking in rats 
(Shaham et al., 1998) or mice (our own unpublished data) as well as 
stress-induced reinstatement following heroin (Shaham et al., 1997), 
alcohol (Lê et al., 2000), and nicotine (Bruijnzeel et al., 2009) SA. 
4.2.2. Role for CRF-R2 receptors  
A role for the CRF-R2 receptor in stress-induced relapse has also 
been reported (Wang et al., 2005, 2007). In these studies, which 
involved more prolonged delivery into the VTA via reverse micro-
dialysis, it was found that reinstatement by footshock or intra-VTA CRF 
delivery was blocked by antagonists at CRF-R2 but not CRF-R1 
receptors. The mechanism of action in these studies appeared to 
involve CRF interactions with the CRF binding protein. Agents that 
displace CRF from its binding protein prevented reinstatement and the 
corresponding neurochemical changes in the VTA while only CRF-R2 
agonists that also interact with the binding protein induced cocaine 
seeking (Wang et al., 2007). Notably, this finding is consistent with a 
report that CRF can potentiate NMDA receptor mediated synaptic 
transmission in the VTA through a similar mechanism (Ungless et al., 
2003). Differences in the mode and duration of CRF/antagonist 
delivery, as well as the experimental history of the rats likely 
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contributed to the disparate findings regarding the role of CRF receptor 
subtypes in stress-induced cocaine seeking. Nonetheless, the 
implication of both receptors is not particularly surprising, considering 
the VTA expression profile of CRF receptors (both subtypes are 
expressed on DA and non-DA cells and likely on nerve terminals) as 
well as the complexity of CRF actions in the VTA. 
4.3. CRF actions in the VTA 
CRF has been reported to produce both excitatory (Wanat et al., 
2008; Korotkova et al., 2006) and inhibitory (Beckstead et al., 2009) 
effects on DA neuronal activity in the VTA, to alter synaptic integration 
via intracellular calcium mobilization in DA cells (Riegel and Williams, 
2008), and to promote excitatory synaptic transmission through post-
synaptic trafficking of NMDA and AMPA receptors (Ungless et al., 
2003; Hahn et al., 2009). Additionally, CRF promotes glutamate 
release in the VTA as measured using in vivo microdialysis (Wang et 
al., 2005), a finding that is consistent with reports that CRF also 
increases the frequency of AMPAR-mediated spontaneous miniature 
EPSCs in DA cells in slice preparations (Hahn et al., 2009). Based on 
its effects on excitatory neurotransmission, it has been proposed that 
the primary function of CRF in the VTA during stress is to excite DA 
cells, thereby activating mesocorticolimbic neurotransmission and 
promoting drug use (Wise and Morales, 2010). Consistent with this 
hypothesis, CRF delivery into the VTA increases local DA release 
measured during reinstatement testing (Wang et al., 2005), while 
glutamate receptor antagonism in the VTA prevents both increases in 
local DA levels and stressor- and CRF-induced reinstatement (Wang et 
al., 2005). However, with the exception of a small group of DA cells in 
the most ventral aspects of the VTA (Brischoux et al., 2009), the time-
locked response of DA cells in the VTA to stressful/aversive stimuli in 
the absence of drug-associated context is a reduction in firing rate 
(Ungless et al., 2004, 2010). Likewise, the time-locked DA response in 
the NAc to such stimuli, as measured using voltammetry, is also a 
decrease (Badrinarayan et al., 2012; Roitman et al., 2008; Oleson et 
al., 2012). Taken together, these findings suggest that the mesolimbic 
DA response to stressful/aversive stimuli is somewhat incompatible 
with a model that assumes that increased CRF release into the VTA will 
evoke drug seeking simply by exciting dopaminergic efferents. 
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It is intriguing to speculate that, rather than producing direct 
excitatory effects in the VTA, CRF serves as a coordinator of VTA 
function – generally silencing DA cellular activity in the absence of 
drug-associated stimuli, while opportunistically promoting signaling via 
key excitatory inputs that relay drug-related/appetitive information to 
the VTA. Consistent with this possibility, it has been reported that CRF 
receptor antagonism increases DA neuron population activity in the 
VTA but attenuates evoked DA release in the NAc (Lodge and Grace, 
2005). This coordinating function of CRF in the VTA could position it as 
a key determinant of stimulus salience and coping behaviors during 
periods of stress and may have implications not only for addiction but 
also for under-standing other conditions associated with aberrant 
stress-related behavioral responses. 
Adding to the difficulty in understanding CRF function in the VTA 
is the anatomical complexity of the region. While often studied as a 
uniform structure in terms of cellular composition and connectivity, the 
VTA is comprised of both DA and non-DA (i.e., local and projecting 
GABAergic and glutamatergic) cell types (Steffensen et al., 1998; Dobi 
et al., 2010; Yamaguchi et al., 2011) that are differentially regulated 
during periods of stress depending on their anatomical localization, the 
neurochemical context at the time of stimulation and differences in 
their intrinsic properties that may render them differentially responsive 
to the same input. The potential significance of this differential 
responsiveness to motivated behavior is evident when considering that 
the putative pathway responsible for stress-induced cocaine seeking 
involves reciprocating connectivity between the VTA and the BNST and 
NAc shell that ultimately regulates the activity of a key DA projection 
from the VTA to the mPFC (McFarland et al., 2004). Therefore, the 
possibility that CRF differentially regulates distinct neuronal sub-
populations in the VTA, possibly in a receptor subtype-dependent 
manner, cannot be ruled out. Indeed, CRF-R1 receptors are 
heterogeneously expressed on multiple cell types in the VTA 
(Korotkova et al., 2006; Refojo et al., 2011) and the behavioral 
consequences of CRFR-1 receptor deletion these different cell types 
(GABAergic vs. glutamatergic vs. dopaminergic) varies significantly 
(Refojo et al., 2011). 
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4.4. CRF-releasing projections to the VTA 
The sources of CRF release into the VTA appear to include 
projections that originate from several regions known to be critical 
regulators of stress-related hormonal and behavioral responses, 
including the CeA, the paraventricular nucleus of the hypothalamus, 
and BNST (Rodaros et al., 2007). CRF-containing projections to the 
VTA appear to be both glutamatergic and GABAergic, suggesting that 
co-released CRF can participate in both excitatory and inhibitory 
transmission (Tagliaferro and Morales, 2008). However, most of the 
direct innervation of tyrosine hydroxylase-positive cells appears to be 
glutamatergic (Tagliaferro and Morales, 2008). The nature of the 
connectivity with other VTA cell types has not been determined. In 
light of studies demonstrating that the BNST is critical for stress-
induced cocaine seeking (McFarland et al., 2004; Briand et al., 2010), 
we have recently begun to examine the importance of this CRF-
releasing BNST to VTA projection in stress-induced relapse and its 
regulation by noradrenergic neurotransmission. Importantly, while 
much research, including our own, has focused on the involvement of 
the BNST-to-VTA pathway, CRF-releasing projections from other 
regions likely also contribute to relapse. For example, it has been 
reported that inhibition of the CeA prevents stress-induced cocaine 
seeking (McFarland et al., 2004). It is tempting to speculate that the 
release of CRF into the VTA from multiple pathways and its actions on 
functionally distinct sub-populations of cells in the VTA account for the 
complicated and often seemingly contradicting literature describing 
CRF’s actions in the region. 
5. Norepinephrine 
Central noradrenergic signaling has been implicated in a number 
of stress-related processes, including stress-induced relapse. Key 
sources of central noradrenergic projections include the locus 
coeruleus (A6 region) and groups of nuclei in the pons and rostral 
medulla (A1, A2, A5, and A7) whose projections collectively comprise 
the ventral noradrenergic bundle (VNAB). Adrenergic receptors bound 
by centrally released NE are primarily G-protein coupled and include 
Gs-coupled beta-1, beta-2 and beta-3 adrenergic receptors, Gq-coupled 
alpha-1 adrenergic receptors, and Gi-coupled alpha-2 adrenergic 
receptors. Noradrenergic innervation and adrenergic receptor 
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expression in the CNS is widespread and includes a number of regions 
implicated in stress-induce cocaine seeking, including the NA shell, 
mPFC, and the BNST (Berridge, 2008). 
5.1. NE and stress-induced relapse 
An important role for noradrenergic signaling in stress-induced 
relapse has been established. We and others have shown that 
functional antagonism of noradrenergic signaling via administration of 
alpha-2 adrenergic receptor agonists such as clonidine prevents 
footshock-induced reinstatement in rats (Erb et al., 2000) and swim-
induced reinstatement in mice (Mantsch et al., 2010). Conversely, the 
activation of central noradrenergic neurotransmission through alpha-2 
adrenergic autoreceptor antagonism by drugs such as yohimbine is 
sufficient to reinstate cocaine seeking in rats (Feltenstein and See, 
2006; Brown et al., 2009), monkeys (Lee et al., 2004) or mice 
(Mantsch et al., 2010; Vranjkovic et al., 2012). These reinstating 
effects can be reproduced by central (icv) administration of NE in rats 
(Brown et al., 2011). Like CRF, the role of NE in reinstatement appears 
to be specific to stress, as alpha-2 adrenergic receptor agonists fail to 
attenuate cocaine-primed reinstatement in rats or mice (Erb et al., 
2000; Mantsch et al., 2010). The potential utility of targeting 
noradrenergic neurotransmission for managing stress-induced relapse 
in cocaine addicts is supported by findings that alpha-2 adrenergic 
receptor agonists prevent stress-induced craving in human cocaine-
dependent subjects (Jobes et al., 2011; Fox et al., 2012). 
5.2. Role of adrenergic receptors in stress-induced 
reinstatement 
Using the mouse CPP/reinstatement approach, we have 
identified an important role for beta, but not alpha-1 adrenergic 
receptors in stress-induced relapse. Reinstatement following forced 
swim or yohimbine administration is prevented by pretreatment with 
the beta adrenergic receptor antagonist, propranolol, but not by the 
alpha-1 adrenergic receptor antagonist, prazosin (Mantsch et al., 
2010) and is reproduced by administration of the beta adrenergic 
receptor agonist, isoproterenol (Vranjkovic et al., 2012). Furthermore, 
forced swim fails to produce reinstatement in beta adrenergic 
receptor-deficient mice (Vranjkovic et al., 2012). More specifically, 
stress-induced reinstatement appears to require the beta-2 but not the 
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beta-1 adrenergic receptor. Reinstatement following forced swim or 
alpha-2 receptor antagonism is blocked by pretreatment with the beta-
2 adrenergic receptor-selective antagonist, ICI-188,551, but not the 
beta-1 adrenergic receptor-selective antagonist betaxolol, while 
administration of the beta-2 adrenergic receptor-selective agonist, 
clenbuterol, is sufficient to reinstate (Vranjkovic et al., 2012). In situ 
hybridization and auto-radiography studies have demonstrated that 
beta-2 adrenergic receptors are expressed in a number of brain 
structures that have been implicated in stress-induced relapse, 
including the PFC and structures that comprise the extended amygdala 
complex (Asanuma et al., 1991; Rainbow et al., 1984). However, the 
finding that beta adrenergic receptor blockade in the BNST using a 
cocktail of beta-1 and beta-2 receptor antagonists prevents footshock-
induced reinstatement in rats (Leri et al., 2002) has led to the 
hypothesis that beta-2 adrenergic receptor activation of a CRF-
releasing projection from the BNST to the VTA is critical for stress-
induced cocaine use. 
5.3. BNST connectivity with the VTA 
As described above (Section 3.2), the BNST is required for 
stress-induced reinstatement of extinguished cocaine seeking following 
SA in rats (McFarland et al., 2004) and CPP in mice (Briand et al., 
2010) and sends projections to the VTA that co-release CRF (Rodaros 
et al., 2007). Both glutamatergic and GABAergic projections from the 
BNST to the VTA have been characterized (Georges and Aston-Jones, 
2002; Kudo et al., 2012; Jennings et al., 2013) and a recent 
disconnection study showing attenuated expression of CPP following 
contralateral inhibition of the BNST in one hemisphere and VTA of the 
other supports a functional role for this pathway in cocaine seeking 
(Sartor and Aston-Jones, 2012). Recent work by Stuber and colleagues 
(Jennings et al., 2013), has provided a more comprehensive picture of 
the anatomy and function of BNST projections to the VTA. Both 
glutamatergic and GABAergic projections to the VTA are activated 
during stress but exert functionally divergent regulation of stress-
related behaviors. Notably, both circuits primarily innervate non-DA 
cells in the VTA and most of the direct innervation of DA cells appears 
to be GABAergic (Jennings et al., 2013). It has not yet been 
determined which of the projections from the BNST co-releases CRF, 
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nor has the relative contribution of these distinct pathways to stress-
induced cocaine seeking. 
5.4. Noradrenergic neurotransmission in the BNST and 
stress-induced relapse 
The BNST receives dense noradrenergic innervation, much of 
which consists of projections from medullary cell groups conducted as 
part of the VNAB (Shin et al., 2008). Indeed, it has been reported that 
disruption of the locus coeruleus fails to attenuate stress-induced drug 
seeking following opiate SA or opiate-induced CPP, while lesion of the 
VNAB or inhibition of more caudal adrenergic cell groups prevents 
stress-induced reinstatement (Shaham et al., 2000; Wang et al., 
2001). Both alpha and beta adrenergic receptor subtypes are 
expressed in the BNST (Rainbow et al., 1984; Asanuma et al., 1991; 
Day et al., 1997; Shields et al., 2009). However, it has been found 
that beta adrenergic receptors in the BNST are particularly important 
for stress-induced cocaine seeking. Leri et al. (2002) reported that 
administration of a cocktail consisting of betaxolol and ICI-118,551 
into the BNST dose-dependently attenuated footshock-induced 
reinstatement in rats. We have reproduced these findings with 
administration of ICI-118,551 into the BNST by itself (unpublished 
findings), suggesting that beta-2 adrenergic receptor activation in the 
BNST is necessary for stress-induced relapse. In the BNST, beta 
adrenergic facilitation of both GABAergic (Dumont and Williams, 2004) 
and glutamatergic (Egli et al., 2005; Nobis et al., 2011 regulation of 
neuronal function has been reported. Recently, we have provided more 
direct evidence for a beta-2 adrenergic receptor-regulated, CRF-
releasing pathway from the BNST to the VTA; ICI-118,551 
administration in the BNST of one hemisphere and contralateral CRF-
R1 receptor antagonism using antalarmin in the VTA of the other 
hemisphere prevents footshock-induced reinstatement (unpublished 
data). Altogether, these findings establish the likely importance of a 
beta-2 adrenergic regulated CRF-releasing pathway to the VTA for 
stress-induced cocaine use. 
5.5. NE regulation of CRF in the BNST 
Although the exact mechanism through which beta adrenergic 
receptors regulate projections from the BNST to the VTA has not been 
fully characterized, recent evidence suggests that it likely involves 
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effects on CRF release into the BNST and the resulting activation of 
CRF-R1 receptors. Like the VTA, CRF-R1 receptor activation in the 
BNST is necessary for stress-induced reinstatement (Erb and Stewart, 
1999). The source of CRF in the BNST is unclear and may involve 
release from terminals of neurons that project into the region 
(Beckerman et al., 2013) or from local cell populations (Silberman et 
al., 2013). The BNST receives a strong projection from the CeA (Zahm 
et al., 1999) and this projection appears to be required for stress-
induced reinstatement, since inhibition of the CeA–BNST pathway via 
TTX administration in the CeA in one hemisphere and contralateral CRF 
receptor antagonism in the BNST of the other hemisphere prevents 
footshock-induced reinstatement (Erb et al., 2001). In the BNST, CRF 
facilitates excitatory regulation of efferent projections (Kash et al., 
2008; Nobis et al., 2011), including those that innervate the VTA 
(Silberman et al., 2013), likely via activation of CRF-R1 receptors on 
glutamatergic terminals (Silberman et al., 2013). We hypothesize that, 
ultimately, these beta-2 adrenergic receptor-regulated processes in 
the BNST increase the activity of CRF-releasing projections to the VTA. 
Although this hypothesis has not been directly tested, it has been 
found that icv administration of a CRF receptor antagonist blocks 
reinstatement by central NE delivery, while functional antagonism of 
noradrenergic neurotransmission via clonidine fails to affect 
reinstatement following icv administration of CRF (Brown et al., 2009). 
6. Intake-dependent emergence of stress-induced 
reinstatement 
The contribution of stress to drug use is not uniform across all 
cocaine users and appears to vary significantly based on a number of 
factors, including the context within which stress is encountered, 
genetic predisposition, and, importantly, the history of prior cocaine 
use. For example, it has been reported that a prior history of higher 
frequency cocaine use is associated with augmented stress-induced 
craving measured in a laboratory setting in cocaine-dependent 
individuals (Fox et al., 2005). A possible explanation for the 
relationship between heightened sensitivity to stress-induced craving 
and previous drug use is that repeated drug exposure establishes 
intake-dependent neuroplasticity that renders addicts more susceptible 
to stressor-induced cocaine seeking. 
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6.1. Long-access cocaine SA 
One approach that can be used to investigate persistent drug-
induced neuroplasticity related to heightened use involves the study of 
rats provided chronic daily prolonged access to cocaine for SA (Ahmed 
and Koob, 1998). Using this approach, Koob and colleagues have 
demonstrated that, over time, rats self-administering under these 
conditions display an escalating pattern of cocaine intake that is 
associated with and likely the consequence of the emergence of an 
anhedonic/dysphoric state attributable to the recruitment of a number 
of opponent process mediators, including dynorphin/kappa opioid (Wee 
et al., 2009), endocannabinoid (Orio et al., 2009), noradrenergic (Wee 
et al., 2008), and CRF (Specio et al., 2008) systems (see Koob, 2009 
for review). We and others have found that the consequences of 
extended-access SA are long-lasting and affect cocaine-seeking in 
relapse models, as demon-strated by heightened susceptibility to 
reinstatement in response to cocaine priming (Mantsch et al., 2004), 
presentation of cocaine-associated cues (Kippin et al., 2006), and 
stress (Mantsch et al., 2008a). 
6.2. Establishment of stress-induced reinstatement 
following long-access SA 
Research in our laboratory has focused on how SA history alters 
subsequent susceptibility to stress-induced reinstatement. We have 
found that increasing the amount of prior cocaine SA by allowing rats 
to self-administer cocaine under long-access conditions (14 × 6 h/day) 
that result in very high levels of daily drug intake (approximately 70 
mg/kg/day) augments the ability of electric footshock to reinstate 
cocaine seeking (Mantsch et al., 2008a). Indeed, under the SA and 
shock conditions that we use, robust and reliable reinstatement of 
extinguished cocaine seeking in response to electric footshock, only 
occurs when rats have a history of SA under long-access conditions 
and is not observed in rats with history of SA under conditions of more 
limited access (14 × 2 h/day; approximately 15 mg/kg daily intake; 
Mantsch et al., 2008a). Others have reported shock-induced 
reinstatement of cocaine seeking in the absence of prior testing under 
long-access SA conditions (e.g., Ahmed and Koob, 1997; McFarland et 
al., 2004). However, since susceptibility to reinstatement is likely also 
determined by environmental variables (e.g., food restriction, time of 
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day, handling, and experimental context) and genetic factors (e.g., rat 
strain), we do not view our findings as disparate, especially 
considering that we have optimized our approach to study the ability 
of SA history to influence later cocaine seeking as measured using the 
reinstatement approach. Notably, other groups have similarly reported 
that footshock does not reliably induce rein-statement after short-
access cocaine SA (e.g., Shelton and Beardsley, 2005). 
6.2.1. Neuroadaptations that underlie heightened susceptibility 
to stress-induced relapse  
Recognizing that the ability of stressors to trigger relapse is 
likely influenced by intake-dependent cocaine-induced neuroplasticity, 
we have begun to search for neuroadaptations in the pathways that 
underlie stress-induced cocaine seeking that are associated with long-
access cocaine SA. Not surprisingly, repeated cocaine exposure has 
been found to produce widespread alterations in synaptic strength, 
structure, and regulation, many of which have the potential to 
influence stress-induced reinstatement and emerge in an intake-
dependent manner with cocaine SA (see Koob and Volkow, 2010 for 
review). A complete inventory of all of these adaptations is well 
beyond the scope of this review. Instead, here we will briefly 
summarize recent findings suggesting that increased responsiveness of 
CRF-regulated processes may contribute to heightened relapse 
susceptibility. 
6.2.2. Augmented CRF responsiveness in the VTA  
Our laboratory has demonstrated that, like stress, the ability of 
intra-VTA CRF administration to reinstate cocaine seeking emerges 
with repeated long-access SA (Blacktop et al., 2011). Bilateral delivery 
of CRF directly into the VTA fails to induce reinstatement in rats with a 
history of short-access SA (2 h/day) but produces robust 
reinstatement when rats have a history of SA under long-access 
conditions (6 h/day), suggesting that at least some of the 
neuroadaptations responsible for establishing stress as a trigger for 
drug use involve processes downstream from the site of CRF action in 
the VTA. These findings are consistent with a report that CRF-R1 
receptor antagonism only interferes with cocaine SA following repeated 
testing under-extended access conditions (Specio et al., 2008). We 
hypothesize that alterations in CRF receptor and/or signaling 
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mechanisms in the VTA contribute to the heightened CRF 
responsiveness. However, since long-access cocaine SA also heightens 
cocaine-primed reinstatement – a process that is independent of CRF 
(Erb et al., 1998; Graf et al., 2011) - it is clear that at least some of 
the contributing neuroplasticity occurs in brain regions downstream 
from CRF receptors in the VTA, likely in the cortico-accumbens 
pathway required for both stress and drug-induced cocaine seeking 
(i.e., in the prelimbic cortex and/or NAc core). Additionally, as the NAc 
shell and BNST have reciprocating connectivity with the VTA that may 
also be regulated by CRF, adaptations in these regions cannot be ruled 
out. 
6.2.3. Potential cocaine-induced neuroadaptations in the VTA  
In the VTA, repeated cocaine administration has been reported 
to increase CRF receptor binding (Goeders et al., 1990) and to alter 
CRF responsiveness. For example, it has been demonstrated that 
repeated cocaine establishes CRF-R1 receptor-mediate regulation of 
glutamatergic synaptic transmission in the VTA (Hahn et al., 2009) 
and attenuates CRF-R1 receptor-induced enhancement of GIRK 
channel-mediated inhibitory post-synaptic currents (Beckstead et al., 
2009). Likewise, a prior history of cocaine SA is required for CRF 
regulation of extracellular DA and glutamate release in the VTA (Wang 
et al., 2005). Interestingly, in this study it was also found that, while 
CRF responsiveness in the VTA was increased by prior SA, stress-
induced CRF release into the VTA was unchanged (Wang et al., 2005). 
Thus, cocaine-induced neuroplasticity that contributes to relapse may 
involve changes in VTA CRF receptors and/or downstream processes 
but not mechanisms (such as those in the BNST) that regulate intra-
VTA CRF release. Importantly, while all of these changes may 
contribute to the heightened stress-induced cocaine seeking observed 
following long-access SA, effects of SA under these conditions on CRF 
receptor expression, function and downstream signaling have not yet 
been reported. 
6.3. Induction of neuroplasticity that contributes to 
stress-induced relapse 
In addition to identifying the neuroplastic changes that underlie 
heightened susceptibility to stress-induced relapse, our laboratory has 
focused on understanding the neurobiological processes through which 
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these changes are put in place. Much of our research has examined 
the role of glucocorticoids as potential mediators of addiction-related 
neuroplasticity. 
6.3.1. Glucocorticoids and relapse-related neuroplasticity  
Glucocorticoids secreted as a consequence of activation of the 
stressor-responsive HPA axis play a critical role in physiological 
processes that enable organisms to effectively adapt to and cope with 
stressors (de Kloet et al., 2008; McEwen, 2008). Although elevated 
glucocorticoids are of short-term benefit to an organism, prolonged 
and/or repeated elevations of glucocorticoids as a result of chronic 
stress are maladaptive and lead to a number of pathological 
conditions, some of which may contribute to addiction. For example, 
we have demonstrated that daily exposure to a stressor, intermittent 
footshock, at the time of SA testing produces a progressive escalation 
of cocaine SA that is dependent on elevated glucocorticoids (Mantsch 
and Katz, 2007). 
6.3.2. Effects of cocaine use on glucocorticoids  
Like stressors, self-administered cocaine increases 
glucocorticoid secretion in rats (Galici et al., 2000), monkeys 
(Broadbear et al., 1999), and human cocaine addicts (Ward et al., 
1999). When rats self-administer cocaine during prolonged sessions, 
increases in plasma corticosterone are greater and more persistent 
than they are with short-access SA (Mantsch et al., 2003) and 
physiological signs of increased glucocorticoid secretion (e.g., 
reductions in thymus weight and adrenal hypertrophy) are 
exaggerated. Thus, any contribution of elevated glucocorticoids to 
cocaine-induced neuroplasticity will likely be particularly pronounced in 
rats self-administering cocaine under conditions of prolonged daily 
drug access. 
6.3.3. Role of elevated glucocorticoids during cocaine use in the 
induction of relapse-related plasticity  
To examine the potential contribution of elevated glucocorticoids 
to the increased susceptibility to later stress-induced rein-statement 
that emerges with excessive cocaine use, we eliminated the 
glucocorticoid response to cocaine through surgical adrenal-ectomy 
along with basal corticosterone replacement before allowing rats to 
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self-administer for 14 days under long-access conditions and 
subsequently testing for stress and CRF-induced reinstatement (Graf 
et al., 2011). While eliminating the adrenal response to cocaine SA 
had only very modest effects on cocaine intake and extinction, 
subsequent reinstatement in response to footshock or icv CRF delivery 
was completely abolished. By contrast, when rats underwent 
adrenalectomy following repeated SA but prior to reinstatement 
testing (i.e., after cocaine-dependent neuroplasticity was put in place), 
footshock- or CRF-induced cocaine seeking was unaffected, suggesting 
that elevated glucocorticoids at the time of cocaine use are critical for 
establishing neuroadaptations that render addicts susceptible to 
stress-induced relapse. Although elevated glucocorticoids appear to be 
necessary for the effects of long-access cocaine SA, increasing 
glucocorticoids alone during SA does not appear to be sufficient for the 
establishment of relapse vulnerability, as daily administration of 
corticosterone to adrenalectomized rats at doses that reproduce the 
increases plasma levels observed during long-access SA fails to restore 
later reinstatement (Mantsch et al., 2008b). This finding is consistent 
with our earlier report that elevated corticosterone is necessary but 
not sufficient for the effects of repeated stress on cocaine seeking 
(Mantsch and Katz, 2007). Notably, the inability of corticosterone 
alone to restore reinstatement in adrenalectomized rats suggests that, 
during long-access SA, corticosterone may be working in concert with 
another adrenal hormone to establish relapse susceptibility e a finding 
that is consistent with reports that cocaine-induced behavioral 
sensitization requires drug-induced increases in both corticosterone 
and epinephrine (de Jong et al., 2009). The potential interaction 
between glucocorticoids and other hormones/processes that are 
elevated/active during cocaine long-access SA requires further 
investigation. 
6.3.4. Potential mechanisms underlying glucocorticoid-
dependent cocaine-induced neuroplasticity  
Glucocorticoids produce both glucocorticoid receptor (GR) 
mediated genomic effects via transcriptional regulation (de Kloet et al., 
2008) and rapid non-genomic effects mediated via a number of 
mechanisms including actions at a putative membrane-associated G-
protein-coupled receptors that can regulate endocannabinoid 
production (Tasker et al., 2006) and inhibition of the glucocorticoid 
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sensitive monoamine transporter, organic cation transporter 3 (Gasser 
et al., 2006). To date, most studies have examined the potential role 
of GRs in the establishment of cocaine addiction-related 
neuroplasticity. GRs are expressed throughout the neurocircuitry 
implicated in stress-induced cocaine seeking, including in CRF-
expressing cells in the BNST (Cintra et al., 1987), DA cells in the VTA 
(Harfstrand et al., 1986), stress responsive cells in the mPFC 
(Ostrander et al., 2003), and a variety of cell types in the NAc (Zoli et 
al., 1990). In these regions, GR regulation of key stress-responsive 
processes has been demonstrated, including CRF mRNA expression in 
the BNST (Schulkin et al., 1998), glutamatergic responsiveness of DA 
cells in the VTA (Saal et al., 2003), dendritic morphology (Wellman, 
2001) and dopaminergic signaling (Butts et al., 2011) in the mPFC, 
and glutamatergic neurotransmission in the NAc (Campioni et al., 
2009). Thus, GRs are well positioned as potential mediators of 
glucocorticoid-dependent neuroplasticity that establishes stress-
induced cocaine seeking. Although the role of GRs in the effects of 
long-access cocaine SA on stress-induced reinstatement has not been 
examined, their role in establishing behavioral sensitization and the 
reinforcing effects of cocaine has. Constitutive knockout of GRs 
prevents cocaine-induced behavioral sensitization and attenuates the 
reinforcing effects of cocaine (Deroche-Gamonet et al., 2003), while 
forebrain GR overexpression produces the opposite effect (Wei et al., 
2004). One key site of GR mediation of cocaine-induced effects is in 
DA receptive neurons in the NA. Selective deletion of GRs in these cells 
attenuates cocaine SA (Ambroggi et al., 2009) as well as cocaine-
induced behavioral sensitization and CPP (Barik et al., 2010). Future 
studies will be required to determine if GR antagonism during long-
access cocaine SA can prevent the effects on subsequent stress-
induced reinstatement. 
7. “Stage setting” effects of stress for drug 
relapse 
Our findings that the ability of stressors to reinstate cocaine 
seeking is only observed when rats have a history of long-access 
cocaine SA (Mantsch et al., 2008a) seem to indicate that stress-
triggered relapse may only occur in cocaine addicts with a pro-longed 
history of excessive drug use. This should not be misinterpreted to 
imply that stressful life events only contribute to relapse in the most 
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extreme addicts. In fact, in many individuals, the role of stress in their 
drug use is more subtle and, rather than simply functioning as a 
trigger for drug use, appears to involve a more complex interaction 
between stress and drug-associated cues and/or cocaine itself. 
Accordingly, there are some reports in cocaine-dependent individuals 
that stress imagery alone is insufficient to directly elicit drug craving 
(De La Garza et al., 2009) and that stressors, such as memories of 
traumatic events (Coffey et al., 2002) or exposure to painful stimuli 
(Duncan et al., 2007), function by increasing reactivity to drug-related 
cues rather than directly evoking craving on their own. This “stage 
setting” effect of stress is consistent with findings in rats 
demonstrating that stress-induced reinstatement of cocaine-seeking 
behavior requires the presence of cues previously associated with 
cocaine availability (Shelton and Beardsley, 2005) and that acute 
stressors increase the magnitude of reinstatement triggered by 
cocaine-associated cues (Feltenstein and See, 2006; Buffalari and See, 
2009) or by administration of a dose of cocaine that by itself is 
insufficient to reinstate (Graf et al., 2013). 
Recently, we have reported that the “stage-setting” effects of 
stress are prevented by surgical adrenalectomy and reproduced by 
administration of corticosterone at a dose that establishes plasma 
levels in the stress-induced range (Fig. 3; Graf et al., 2013). Thus, 
glucocorticoids are both sufficient and necessary for the stress-induced 
potentiation of cocaine-induced reinstatement. It appears that 
corticosterone augments reinstatement by direct actions in the nucleus 
accumbens that result in potentiation of the dopamine response to 
cocaine via a rapid, GR-independent inhibition of dopamine clearance 
that does not involve the dopamine transporter (DAT; Graf et al., 
2013). Glucocorticoids have long been known to acutely block the 
clearance of monoamines via uptake2, a high-capacity transport 
system first characterized in peripheral tissues (Iversen and Salt, 
1970). More recently uptake2 has been attributed to a collection of 
transporters that includes the organic cation transporters (OCTs 1, 2 
and 3) and the plasma membrane monoamine transporter (PMAT). 
Each of these transporters is capable of transporting DA, albeit with 
varying efficiency (Duan and Wang, 2010; Gorboulev et al., 2005; 
Gründemann et al., 1998) and most are expressed in the brain 
(Amphoux et al., 2006; Engel et al., 2004; Vialou et al., 2008; Gasser 
et al., 2009). However, only one of these transporters, OCT3, is 
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blocked by physiological, stress-induced corticosterone concentrations 
(Gasser et al., 2006). We have demonstrated that OCT3 is expressed 
on DA D1 receptor-expressing medium spiny neurons in the nucleus 
accumbens in close proximity to tyrosine hydroxylase positive nerve 
terminals (Gasser et al., 2009; Graf et al., 2013) and that 
administration of corticosterone or the non-glucocorticoid inhibitor of 
OCT3, nor-metanephrine, directly into the nucleus accumbens 
increases cocaine responsiveness via a mechanism that requires DA 
receptor activation (Graf et al., 2013). 
 
Fig. 3 Stress-induced potentiation of cocaine-primed drug seeking behavior is 
corticosterone-dependent, but does not require GR activation. Reproduced from Graf 
et al. (2013) with permission from the Journal of Neuroscience. (A, B) Cocaine lever 
responses on the last day of extinction and during reinstatement testing of (A) 
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adrenal-intact or (B) adrenalectomized rats. On the day of reinstatement testing, rats 
were subjected to 15 min of uncontrollable, intermittent electric footshock (EFS) or no 
shock, followed by injection of cocaine (2.5 mg/kg ip) or saline, and cocaine lever 
responses were recorded for 2 h. (C) Acute corticosterone injection mimics stress-
induced potentiation of reinstatement. Rats received an injection of corticosterone 
(CORT; 2.0 mg/kg ip) or vehicle followed, 40 min later, by an injection of cocaine (2.5 
mg/kg ip) or saline. (d) RU38486 pretreatment has no effect on corticosterone-
induced potentiation of reinstatement. Rats received an injection of the GR antagonist 
RU38486 (12.5 mg/kg sc) or vehicle, followed 60 min later by injection of 
corticosterone (2.0 mg/kg ip) or vehicle, followed 40 min thereafter by an injection of 
cocaine (2.5 mg/kg ip). *indicates significantly different from extinction responding (P 
< 0.05). Error bars represent mean ± s.e.m. 
While these data point to corticosterone-mediated regulation of 
dopamine clearance as a key mechanism through which stress can “set 
the stage” for cocaine use, other corticosterone-dependent 
mechanisms may also be involved. Current areas of investigation 
include corticosterone-induced increases in endocannabinoid 
production and resulting alterations in the excitability of the cortico-
accumbens glutamatergic pathway that mediates cocaine seeking. To 
date, our preliminary findings have revealed important roles 
endocannabinoids in these “stage setting” effects in part via actions in 
the prelimbic cortex. Interestingly, neither glucocorti-coids (Erb et al., 
1998; Graf et al., 2011) nor endocannabinoids (De Vries et al., 2001) 
appear to be required for reinstatement by stress alone, suggesting 
that the mechanisms for the relapse-triggering and promoting effects 
of stress may be non-overlapping. 
8. Summary and treatment implications 
In summary, recent research in our laboratory has advanced our 
understanding of the neurobiological processes through which stressful 
stimuli contribute to cocaine use. A schematic depicting some of these 
mechanisms is shown in Fig. 2. It is our hope that, from this better 
understanding, new and more effective interventions for the 
management of cocaine addiction will arise. Indeed, currently available 
medications and new drugs in development targeting adrenergic, CRF, 
glucocorticoid and cannabinoid receptors as well as cognitive 
behavioral approaches focused on stress management may represent 
powerful tools through which the contribution of stress to the addiction 
process can be minimized, at least in the case of cocaine. Notably, 
although the mechanisms through which stress influences drug use 
may vary with the class of abused drug, many of the processes likely 
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also contribute to stress-related use of a number of drugs, including 
opiates, alcohol, and nicotine. For example, it has been reported that 
stress-induced reinstatement of drug seeking following heroin 
(Shaham et al., 1997), alcohol (Lê et al., 2000) or nicotine (Bruijnzeel 
et al., 2009) SA involves CRF, as does stress-induced reinstatement of 
palatable food-seeking behavior (Ghitza et al., 2006). Confirmation of 
the relevance of the pathways and pathways described in this review 
to stress-induced relapse of use of these other drugs awaits more 
detailed investigation. Although the contribution of stress to drug use 
likely varies across individual addicts, we are optimistic that advances 
in the diagnosis of addiction that will permit the identification of 
individuals whose drug use is stress-related, along with the availability 
of effective stress-targeting therapeutics approaches, will lead to 
better treatment outcomes and improve lives. 
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